Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) climbed 5.5% Tuesday as the U.S. Food and Drug Administration approved ...

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the ...

ONAPGOis the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s ...

Continuous Subcutaneous Infusion of Foscarbidopa and Foslevodopa (Vyalev) The Vyalev system involves continuous subcutaneous infusion of foscarbidopa and foslevodopa. Unlike traditional oral ...

The real estate investment trust (REIT) arm of Filinvest Land Inc. (FLI) is estimating at least 30-percent growth in ...

Educators and families say the recent infusion of school funding from the state is helping. When evidence of that will show ...

ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson's diseaseONAPGO is a wearable subcutaneous infusion devi ...

The new cancer hub will be located within the UH TriPoint Physician Pavilion, connected to UH TriPoint Medical Center.

The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat ...

WeWork India’s IPO marks a pivotal moment for the country’s flexible workspace sector. With a pure offer-for-sale structure ...

Apellis' C3 inhibitor Empaveli (pegcetacoplan) is also approved for PNH, and is given by subcutaneous infusion, but remains a relatively minor product with sales of less than $25 million in the ...